Search filters

List of works by Christine Lebrun-Frenay

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

scientific article published on 4 November 2016

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

scientific article published on 12 June 2013

Acute fulminant demyelinating disease: a descriptive study of 60 patients

scientific article published on 01 October 2007

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

scientific article published on 19 December 2014

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

scientific article published on 29 September 2013

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

scientific article published on February 2014

Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs

scientific article published on 01 October 2018

Cavitary lesions in multiple sclerosis: multicenter study on twenty patients

scientific article

Cervical spinal cord atrophy: An early marker of progressive MS onset

scientific article published on 22 January 2018

Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies

scientific article published on 6 January 2017

Choosing the right dopamine agonist for patients with Parkinson's disease.

scientific article

Cognitive functions in neuromyelitis optica.

scientific article published in January 2008

Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study.

scientific article published on 27 November 2017

EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.

scientific article

Early CNS neurodegeneration in radiologically isolated syndrome.

scientific article

Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment

scientific article published on 25 July 2020

Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.

scientific article

Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome.

scientific article published in October 1998

Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'.

scientific article published on 16 March 2017

Evolution of nevi during treatment with natalizumab: A prospective follow-up of patients treated with natalizumab for multiple sclerosis

scientific article published on 20 September 2010

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

scientific article (publication date: 2015)

Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France

article

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).

scientific article published on 13 February 2017

High doses of biotin in chronic progressive multiple sclerosis: a pilot study

scientific article published on 24 January 2015

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

scientific article published in May 2015

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

scientific article published on 10 February 2016

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.

scientific article published on September 2016

Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.

scientific article published on 6 July 2017

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

scientific article published on 10 December 2013

Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?

scientific article published on 31 March 2017

Multiple sclerosis treatments and the anti-JCV antibody index.

scientific article published on 2 November 2017

Natural history of multiple sclerosis with childhood onset.

scientific article published in June 2007

Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab

scientific article published on 22 February 2016

New insights into the burden and costs of multiple sclerosis in Europe: Results for France

scientific article published on August 2017

Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event

scientific article published on 19 November 2010

Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event

scientific article published on 04 June 2020

Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.

scientific article published on 12 July 2013

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

scientific article

Symptomatic giant Virchow-Robin spaces

scientific article published on 9 October 2013

Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion

scientific article published on 22 December 2009

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

scientific article published on June 2017

Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: Yes ⬇️

scientific article published on November 1, 2012

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility

scientific article published on March 2011

Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.

scientific article published on 18 May 2015

[Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].

scientific article

[Gliomas and BRCA genes mutations: fortuitous association or imputability?].

scientific article

[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments]

scientific article published on 04 October 2013

[Neuroepidemiology. Editorial]

scientific article published on 04 June 2009

[Pain in multiple sclerosis]

scientific article published on 01 September 2001

[TNF inhibitors and myelitis: think about it, even lately]

scientific article published on 01 September 2014

Paulina is supported by:

About Paulina

Help